Articles

  • 1 week ago | drapersonline.com | James Knowles

    Exclusive subscription benefits Unlimited use of drapersonline.com Premium monthly magazine Early access to interactive digital edition Exclusive discounts to Drapers conferences Industry-leading reports Drapers’ market-leading buying guides Full access to the Drapers digital archive Exclusive subscriber-only content Subscribe today Here’s a full list of our subscriber benefits: Unlimited online content: exclusive news, interviews, expert comments and reports Full access to all Drapers...

  • 1 month ago | drapersonline.com | James Knowles

    Exclusive subscription benefits Unlimited use of drapersonline.com Premium monthly magazine Early access to interactive digital edition Exclusive discounts to Drapers conferences Industry-leading reports Drapers’ market-leading buying guides Full access to the Drapers digital archive Exclusive subscriber-only content Subscribe today Here’s a full list of our subscriber benefits: Unlimited online content: exclusive news, interviews, expert comments and reports Full access to all Drapers...

  • 1 month ago | investing.thisismoney.co.uk | James Knowles |Marc J Sale

    RNS Number : 4079Y First Class Metals PLC 25 February 2025 First Class Metals Plc ("First Class Metals", "FCM" or the "Company") Publication of Prospectus and Issue of Equity First Class Metals Plc (LSE: FCM), the Canada-focused precious and base metal explorer, with extensive land holdings in northern Ontario, is pleased to announce that, further to the announcement on 18 December 2024, it has today published a Prospectus ("Prospectus").

  • 1 month ago | share-talk.com | James Knowles

    First Class Metals Plc (LSE: FCM), the Canada-focused precious and base metal explorer, with extensive land holdings in northern Ontario, is pleased to announce that, further to the announcement on 18 December 2024, it has today published a Prospectus (“Prospectus“).

  • Nov 19, 2024 | onlinelibrary.wiley.com | Michelle Fransen |Toby Simon |James Knowles |Joshua Penrod

    Recent publications have questioned the importance of the Plasma Protein Therapeutics Association's (PPTA) results as they relate to source plasma (SP) donor health. A commentary published in Transfusion by Van Remoortel et al. states that the ‘very-low-quality evidence … should not be used to substantiate claims regarding the safety of repeated plasmapheresis’ [1].

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
1K
Tweets
890
DMs Open
No
James Knowles
James Knowles @MrJamesKnowles
22 Jul 24

What does true hyper-personalisation look like? And how can retailers use AI turn theory into reality? The new @RetailWeek @bloomreach_tm deep-dive reveals the steps you need to take https://t.co/LJRla51spH #ecommerce #Retail #artificalintelligence #Marketing

James Knowles
James Knowles @MrJamesKnowles
4 Jul 24

RT @R_Taylor_RW: Amidst election fever, I'm here with a very important announcement....It's Christmas! (in July) 🎄 Download @RetailWeek's…

James Knowles
James Knowles @MrJamesKnowles
6 Jun 24

RT @RetailWeek: Retail 100 is back! Decided by a panel of esteemed journalists and retail analysts, the Retail 100 celebrates the country…